MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from common
stock subscription...
$500,000
Proceeds from notes
payable - related party
$85,904
Net cash provided by
financing activities
$505,522
Canceled cashflow
$80,382
Net increase
(decrease) in cash
$72,551
Canceled cashflow
$432,971
Proceeds from notes
payable
$75,000
Payment of notes payable
- related party
$5,000
Payment to economic
injury disaster loan
-$382
Accounts payable and
accrued expenses
$253,990
Amortization of discount on
royalty obligation
$115,334
Stock based
compensation
$108,375
Loss on settlement of
debt
-$100,000
Imputed interest for
related party advances
$15,236
Prepaid expenses
-$13,388
Depreciation and
amortization
$11,195
Amortization of right-of-use
asset
$10,524
Impairment of intellectual
property
$6,374
Net cash used in
operating activities
-$432,971
Canceled cashflow
$634,416
Net loss
-$859,892
Accounts receivable
$76,889
Grant receivable
$69,694
Upfront purchase price
liability
-$42,503
Lease liability
-$10,523
Royalty liability
$7,886
Back
Back
Cash Flow
BioCorRx Inc. (BICX)
BioCorRx Inc. (BICX)
source: myfinsight.com